The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Works by Rolfes, Leàn
Results: 19
1
2
Feasibility and Educational Value of a Student-Run Pharmacovigilance Programme: A Prospective Cohort Study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
3
The Impact of Experiencing Adverse Drug Reactions on the Patient's Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands.
- Published in:
- 2016
- By:
- Publication type:
- journal article
4
Adverse drug reaction reports of patients and healthcare professionals-differences in reported information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2015, v. 24, n. 2, p. 152, doi. 10.1002/pds.3687
- By:
- Publication type:
- Article
5
Electronic Health Record-Triggered Research Infrastructure Combining Real-world Electronic Health Record Data and Patient-Reported Outcomes to Detect Benefits, Risks, and Impact of Medication: Development Study.
- Published in:
- JMIR Medical Informatics, 2022, v. 10, n. 3, p. 1, doi. 10.2196/33250
- By:
- Publication type:
- Article
6
Insight in the safety profile of antidiabetic agents glucagon‐like peptide‐1 agonists and dipeptidyl peptidase‐4 inhibitors in daily practice from the patient perspective.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 12, p. 1588, doi. 10.1002/pds.5077
- By:
- Publication type:
- Article
7
Response to the validity and reliability of a signal impact assessment tool: statistical issue to avoid misinterpretation.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2016, v. 25, n. 10, p. 1217, doi. 10.1002/pds.4084
- By:
- Publication type:
- Article
8
The validity and reliability of a signal impact assessment tool.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2016, v. 25, n. 7, p. 815, doi. 10.1002/pds.4038
- By:
- Publication type:
- Article
9
Safety profile of non-vitamin K oral anticoagulants (NOACs) from a patient perspective: a web-based cohort event monitoring study.
- Published in:
- Expert Opinion on Drug Safety, 2019, v. 18, n. 9, p. 869, doi. 10.1080/14740338.2019.1645120
- By:
- Publication type:
- Article
10
Fifteen years of patient reporting –what have we learned and where are we heading to?
- Published in:
- Expert Opinion on Drug Safety, 2019, v. 18, n. 6, p. 477, doi. 10.1080/14740338.2019.1613373
- By:
- Publication type:
- Article
11
First experiences with a tool to measure the level of clinical information present in adverse drug reaction reports.
- Published in:
- Expert Opinion on Drug Safety, 2018, v. 17, n. 2, p. 111, doi. 10.1080/14740338.2018.1400008
- By:
- Publication type:
- Article
12
Feedback for patients reporting adverse drug reactions; satisfaction and expectations.
- Published in:
- Expert Opinion on Drug Safety, 2015, v. 14, n. 5, p. 625, doi. 10.1517/14740338.2015.1021775
- By:
- Publication type:
- Article
13
Insight into the Severity of Adverse Drug Reactions as Experienced by Patients.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
14
Surveillance of Drug Safety During Pregnancy: Insight in Current International Activities, Future Intentions and Need for Support of National Pharmacovigilance Centres.
- Published in:
- 2019
- By:
- Publication type:
- journal article
15
What Future Healthcare Professionals Need to Know About Pharmacovigilance: Introduction of the WHO PV Core Curriculum for University Teaching with Focus on Clinical Aspects.
- Published in:
- 2018
- By:
- Publication type:
- journal article
16
Interaction of OTC drug noscapine and acenocoumarol and phenprocoumon.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 5, p. 1041, doi. 10.1111/bcp.13887
- By:
- Publication type:
- Article
17
Does patient reporting lead to earlier detection of drug safety signals? A retrospective comparison of time to reporting between patients and healthcare professionals in a global database.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1514, doi. 10.1111/bcp.13576
- By:
- Publication type:
- Article
18
An evaluation of postmarketing reports of hyperglycaemia associated with dolutegravir for treatment of HIV in Eswatini.
- Published in:
- AIDS Research & Therapy, 2022, v. 19, n. 1, p. 1, doi. 10.1186/s12981-022-00481-0
- By:
- Publication type:
- Article
19
Important information regarding reporting of adverse drug reactions: a qualitative study.
- Published in:
- International Journal of Pharmacy Practice, 2014, v. 22, n. 3, p. 231, doi. 10.1111/ijpp.12056
- By:
- Publication type:
- Article